These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35021423)

  • 1. Molecular Theranostic Agent with Programmed Activation for Hypoxic Tumors.
    Koo S; Bobba KN; Cho MY; Park HS; Won M; Velusamy N; Hong KS; Bhuniya S; Kim JS
    ACS Appl Bio Mater; 2019 Oct; 2(10):4648-4655. PubMed ID: 35021423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncovalent Theranostic Prodrug for Hypoxia-Activated Drug Delivery and Real-Time Tracking.
    Zhao XB; Gao K; Shi YP
    Anal Chem; 2021 Nov; 93(45):15080-15087. PubMed ID: 34743509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-directed and activated theranostic agent: Imaging and treatment of solid tumor.
    Kumar R; Kim EJ; Han J; Lee H; Shin WS; Kim HM; Bhuniya S; Kim JS; Hong KS
    Biomaterials; 2016 Oct; 104():119-28. PubMed ID: 27449948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Activated and Indomethacin-Mediated Theranostic Prodrug Releasing Drug On-Demand for Tumor Imaging and Therapy.
    Peng X; Gao J; Yuan Y; Liu H; Lei W; Li S; Zhang J; Wang S
    Bioconjug Chem; 2019 Nov; 30(11):2828-2843. PubMed ID: 31592652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy.
    Shin WS; Han J; Verwilst P; Kumar R; Kim JH; Kim JS
    Bioconjug Chem; 2016 May; 27(5):1419-26. PubMed ID: 27135737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
    Hu Y; Zeng F
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An activatable theranostic for targeted cancer therapy and imaging.
    Bhuniya S; Maiti S; Kim EJ; Lee H; Sessler JL; Hong KS; Kim JS
    Angew Chem Int Ed Engl; 2014 Apr; 53(17):4469-74. PubMed ID: 24644015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment.
    Kumar R; Han J; Lim HJ; Ren WX; Lim JY; Kim JH; Kim JS
    J Am Chem Soc; 2014 Dec; 136(51):17836-43. PubMed ID: 25402959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
    Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
    ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous H
    Bobba KN; Saranya G; Sujai PT; Joseph MM; Velusamy N; Podder A; Maiti KK; Bhuniya S
    ACS Appl Bio Mater; 2019 Mar; 2(3):1322-1330. PubMed ID: 35021379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-Activated Anticancer Prodrug for Bioimaging, Tracking Drug Release, and Anticancer Application.
    Liu W; Liu H; Peng X; Zhou G; Liu D; Li S; Zhang J; Wang S
    Bioconjug Chem; 2018 Oct; 29(10):3332-3343. PubMed ID: 30192132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Readout Hypoxia Tumor Suppression In Vivo through NIR-Theranostic Activation.
    Zhao YQ; Biswas S; Chen Q; Jia M; Zhou Y; Bhuniya S
    ACS Appl Bio Mater; 2021 Jul; 4(7):5686-5694. PubMed ID: 35006742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine-Targeting Gefitinib Prodrug and its Near-Infrared Fluorescent Theranostic Derivative for Monitoring Drug Delivery and Lung Cancer Therapy.
    Song X; Han X; Yu F; Zhang X; Chen L; Lv C
    Theranostics; 2018; 8(8):2217-2228. PubMed ID: 29721074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-active nanoparticles used in tumor theranostic.
    Wang Y; Shang W; Niu M; Tian J; Xu K
    Int J Nanomedicine; 2019; 14():3705-3722. PubMed ID: 31190820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insight into a Cancer Theranostic Probe: Efficient Cell-Specific Delivery of SN-38 Guided by Biotinylated Poly(vinyl alcohol).
    Dutta D; Alex SM; Bobba KN; Maiti KK; Bhuniya S
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33430-33438. PubMed ID: 27960424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroreductase-Activatable Theranostic Molecules with High PDT Efficiency under Mild Hypoxia Based on a TADF Fluorescein Derivative.
    Liu Z; Song F; Shi W; Gurzadyan G; Yin H; Song B; Liang R; Peng X
    ACS Appl Mater Interfaces; 2019 May; 11(17):15426-15435. PubMed ID: 30945838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.